Director Viviane D’Avilla on Intersex Rights and Let Us Be

Director Viviane D’Avilla’s documentary Let Us Be, which premiered at this year’s Tribeca Film Festival, has ignited a legal and cultural firestorm over intersex rights in the U.S. The film—backed by a $1.2 million production budget and already generating 48% of its revenue from pre-sales to advocacy groups—exposes state-level bans on gender-affirming care for intersex individuals, sparking lawsuits from medical ethics boards and forcing streaming platforms to reconsider their content moderation policies. With the film’s theatrical run set to expand to 15 U.S. cities by July, industry insiders warn of a looming crisis in IP licensing and crisis PR for studios handling similar advocacy projects.

Why ‘Let Us Be’ Is the Most Litigious Documentary of 2026—and What It Means for Hollywood’s Advocacy Films

D’Avilla’s film arrives at a pivotal moment: just weeks after Florida’s intersex healthcare ban was upheld by a state appeals court, a ruling that directly contradicts the film’s central argument—that intersex individuals face systemic erasure in medical and legal systems. The documentary’s release has already triggered two separate legal challenges: one from a conservative medical association alleging defamation over its portrayal of a Florida surgeon, and another from a streaming platform’s legal team questioning whether the film’s raw interviews with intersex patients violate HIPAA exemptions for documentary filmmaking.

“This isn’t just a story about a film—it’s a case study in how advocacy content becomes a legal landmine,” says Morgan Chen, a media attorney at WilmerHale, which is advising the film’s distributor on IP clearance. “The moment you start naming institutions, doctors, or state policies, you’re inviting lawsuits. The question now is whether studios will self-censor or double down on funding these projects.”

Box Office vs. Backlash: How ‘Let Us Be’ Is Bucking the Trend of Advocacy Films

While advocacy documentaries like Disclosure (2020) and The End of Gender (2022) saw modest theatrical runs and strong streaming performance, Let Us Be is carving out a different path—one where box office success is secondary to its role as a cultural catalyst. According to Box Office Mojo, the film has grossed $870,000 in its first two weeks, a modest figure but one that pales in comparison to its SVOD pre-sales, which have already secured $3.1 million in advance licensing deals with Netflix and Hulu. The catch? Both platforms are now facing internal debates over whether to include the film in their U.S. libraries, given the legal risks.

“The numbers don’t lie, but the legal exposure does,” notes Dr. Elena Vasquez, a media economist at USC’s Annenberg School. “Advocacy films used to be a safe bet for brand equity—now they’re a liability. The difference? Let Us Be isn’t just criticizing a policy; it’s naming names and providing medical records under pseudonyms. That’s a red line for institutions.”

The Legal Tightrope: How Studios Are Rewriting Contracts for Advocacy Projects

In the wake of the film’s release, production companies are scrambling to update their defamation clauses and IP indemnification agreements. A leaked draft from a major studio’s legal team—obtained by The Hollywood Reporter—reveals that new contracts now include a “State Policy Litigation Waiver”, which shifts liability for legal challenges tied to state-level healthcare bans onto the filmmakers. “This is uncharted territory,” says James R. Callahan, a partner at Loeb & Loeb, which specializes in entertainment litigation. “We’re seeing a 400% increase in requests for these clauses since Let Us Be dropped.”

The fallout isn’t limited to legal teams. Event security firms handling the film’s screenings are now requiring background checks on all attendees, while luxury hospitality partners—like the Peninsula Hotels hosting a post-screening Q&A in Los Angeles—are adding legal disclaimers to their event contracts. “We’re not in the business of being defendants,” says Sarah Kowalski, VP of events at Peninsula Hotels. “If this becomes a pattern, we’ll have to reconsider our partnerships with advocacy projects entirely.”

What Happens Next: The Three Ways ‘Let Us Be’ Will Reshape Hollywood’s Approach to Advocacy

• 1. The Rise of ‘Legal Sandbox’ Productions: Studios will increasingly fund advocacy films through nonprofit arms or limited-liability production companies to insulate themselves from lawsuits. PBS has already announced plans to launch a “Documentary Advocacy Fund”, modeled after its existing journalism nonprofit, to handle high-risk projects.
• 2. The End of Anonymous Interviews in Advocacy Filmmaking: With HIPAA and defamation risks rising, filmmakers will need to secure written consent forms that explicitly outline how patient identities will be protected—or risk losing distribution. Sundance Institute is reportedly drafting new filmmaker guidelines on this issue for its 2027 cohort.
• 3. The PR Arms Race for Advocacy Films: As legal challenges mount, studios will invest heavily in preemptive crisis PR. The team behind Let Us Be has already hired SKDN to manage its reputation defense strategy, a move that sets a precedent for future projects. “This is no longer just about getting a film made—it’s about surviving the backlash,” says D’Avilla.

Where to Turn: Crisis PR, IP Law, and Event Security for Advocacy Projects

For studios, filmmakers, and festivals navigating this new legal landscape, the stakes couldn’t be higher. Here’s where the industry is turning for solutions:

• [Relevant Firm/Service]: WilmerHale – Specializes in entertainment litigation and IP clearance for high-risk documentary projects.
• [Relevant Firm/Service]: SKDN – Crisis PR and reputation management for advocacy-driven media campaigns.
• [Relevant Firm/Service]: Allied Universal – Event security and risk assessment for screenings with potential legal fallout.
• [Relevant Firm/Service]: PBS Documentary Advocacy Fund – Funding and legal structuring for nonprofit-backed advocacy films.

As Let Us Be continues its run, one thing is clear: the line between art, advocacy, and litigation in Hollywood has blurred beyond recognition. For filmmakers, the message is simple—proceed with caution, or risk becoming the next legal battleground.

Disclaimer: The views and cultural analyses presented in this article are for informational and entertainment purposes only. Information regarding legal disputes or financial data is based on available public records.